T

Tubulis GmbH

29 employees

Tubulis Technologies generates uniquely matched protein-drug conjugates.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical
Antibody Drug Conjugates and Targeted Therapy
Life Science

Date founded

2012

Funding rounds raised

Total raised

$63M

from 15 investors over 15 rounds

T

Tubulis GmbH raised $63M on May 3, 2022

Investors: Evotec, Andera Partners, OCCIDENT, Bayern Kapital GmbH, High-Tech Gründerfonds, BioMedPartners, coparion, Seventure Partners and FundPlus

T

Tubulis GmbH raised $12M on July 21, 2020

Investors: Bayern Kapital GmbH, coparion, BioMedPartners, Seventure Partners, High-Tech Gründerfonds and OCCIDENT

FAQ